Further studies are warranted to determine the potential linkage of the two SNP variants (V256I and R525W) in lung cancers and melanomas and to determine the possible relevance of TOP1MT mutations as a source of mitochondrial diseases and susceptibility to therapies8. This evidence concerns the gene TOP1MT and lung carcinoma.